Literature DB >> 9360846

Oligoclonal peripheral T-cell lymphocytosis as a result of aberrant T-cell development in a cortical thymoma.

D de Jong1, D J Richel, C Schenkeveld, L Boerrigter, L J van 't Veer.   

Abstract

A 42-year-old man presented with a locally invasive cortical thymoma. Before chemotherapy was commenced 36 months after presentation, an unusual peripheral lymphocytosis of 19 x 10(9)/l had slowly developed over time. After the first course of chemotherapy, the lymphocytosis showed a sharp decline to normal absolute cell numbers and subsequently remained at normal levels. Currently, the patient is in stable partial remission and doing well. Immunophenotypic analysis showed a mature T-cell phenotype with 78% TcR-a beta and 16% TcR-gamma delta in the absence of an immature component. Pretreatment Southern blot analysis of peripheral blood mononuclear cells showed an oligoclonal pattern with 13-20 rearranged fragments of different intensity for the TcR beta-gene. TcR gamma also showed a pattern compatible with an oligoclonal proliferation. After treatment, after normalization of absolute blood counts, the distribution of T-cell subsets still showed a slightly aberrant pattern. Immunophenotypic analysis of a blood sample taken 6 months later, also at normal absolute cell counts, showed an increase of thymocytes as well as of mature T cells with a polyclonal pattern on Southern blot analysis. These findings may be interpreted as the result of aberrant positive and negative selection and development of thymocytes in the microenvironment of neoplastic thymic epithelial cells and clonal selection through continuous peripheral stimulation. Moreover, this case stresses the importance of integrated interpretation of clinical, morphological, immunophenotypical, and molecular data to gain insight in unusual clinical problems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360846     DOI: 10.1097/00019606-199708000-00009

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  4 in total

1.  Hypereosinophilia in a patient with invasive thymoma with clonal T-lymphocyte expansion expressing CD4, CD8, and CD25 antigens.

Authors:  Masahiko Sumi; Kosuke Nunoda; Tomonori Mizutani; Yuko Ishii; Akihiko Gotoh; Yukihiko Kimura; Yasuhiro Suga; Tatsuo Ohira; Kuniharu Miyajima; Hiromi Serizawa; Kiyoshi Mukai; Harubumi Kato; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors.

Authors:  Giuseppe Giaccone; Arun Rajan; Arlene Berman; Ronan J Kelly; Eva Szabo; Ariel Lopez-Chavez; Jane Trepel; Min-Jung Lee; Liang Cao; Igor Espinoza-Delgado; John Spittler; Patrick J Loehrer
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

3.  Prognostic value of systemic inflammatory markers and the nutrition status in thymic epithelial tumors with complete resection.

Authors:  Tadashi Sakane; Katsuhiro Okuda; Takuya Matsui; Risa Oda; Tsutomu Tatematsu; Keisuke Yokota; Ryoichi Nakanishi
Journal:  Thorac Cancer       Date:  2022-06-18       Impact factor: 3.223

4.  Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma.

Authors:  Piergiorgio Muriana; Angelo Carretta; Paola Ciriaco; Alessandro Bandiera; Giampiero Negri
Journal:  J Cardiothorac Surg       Date:  2018-11-19       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.